These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 36526090)
1. TNF and IL6/Jak2 signaling pathways are the main contributors of the glia-derived neuroinflammation present in Lafora disease, a fatal form of progressive myoclonus epilepsy. Rubio T; Viana R; Moreno-Estellés M; Campos-Rodríguez Á; Sanz P Neurobiol Dis; 2023 Jan; 176():105964. PubMed ID: 36526090 [TBL] [Abstract][Full Text] [Related]
2. Reactive Glia-Derived Neuroinflammation: a Novel Hallmark in Lafora Progressive Myoclonus Epilepsy That Progresses with Age. Lahuerta M; Gonzalez D; Aguado C; Fathinajafabadi A; García-Giménez JL; Moreno-Estellés M; Romá-Mateo C; Knecht E; Pallardó FV; Sanz P Mol Neurobiol; 2020 Mar; 57(3):1607-1621. PubMed ID: 31808062 [TBL] [Abstract][Full Text] [Related]
3. Beneficial Effect of Fingolimod in a Lafora Disease Mouse Model by Preventing Reactive Astrogliosis-Derived Neuroinflammation and Brain Infiltration of T-lymphocytes. Rubio T; Campos-Rodríguez Á; Sanz P Mol Neurobiol; 2024 Jun; 61(6):3105-3120. PubMed ID: 37971656 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological Modulation of Glutamatergic and Neuroinflammatory Pathways in a Lafora Disease Mouse Model. Mollá B; Heredia M; Campos Á; Sanz P Mol Neurobiol; 2022 Oct; 59(10):6018-6032. PubMed ID: 35835895 [TBL] [Abstract][Full Text] [Related]
6. Deciphering the role of malin in the lafora progressive myoclonus epilepsy. Romá-Mateo C; Sanz P; Gentry MS IUBMB Life; 2012 Oct; 64(10):801-8. PubMed ID: 22815132 [TBL] [Abstract][Full Text] [Related]
7. Phenotype variations in Lafora progressive myoclonus epilepsy: possible involvement of genetic modifiers? Singh S; Ganesh S J Hum Genet; 2012 May; 57(5):283-5. PubMed ID: 22456482 [TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan. Sullivan MA; Nitschke S; Steup M; Minassian BA; Nitschke F Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28800070 [TBL] [Abstract][Full Text] [Related]
9. Astrocytes: new players in progressive myoclonus epilepsy of Lafora type. Rubio-Villena C; Viana R; Bonet J; Garcia-Gimeno MA; Casado M; Heredia M; Sanz P Hum Mol Genet; 2018 Apr; 27(7):1290-1300. PubMed ID: 29408991 [TBL] [Abstract][Full Text] [Related]
10. Trehalose Ameliorates Seizure Susceptibility in Lafora Disease Mouse Models by Suppressing Neuroinflammation and Endoplasmic Reticulum Stress. Sinha P; Verma B; Ganesh S Mol Neurobiol; 2021 Mar; 58(3):1088-1101. PubMed ID: 33094475 [TBL] [Abstract][Full Text] [Related]
18. A novel compound heterozygous EPM2A mutation in a Chinese boy with Lafora disease. Fu Y; Zhou C; Song R; Peng J; Yang X; Xiao B; Zhou J; Long H Neurol Sci; 2020 Aug; 41(8):2267-2270. PubMed ID: 32342326 [TBL] [Abstract][Full Text] [Related]
19. Early-onset Lafora body disease. Turnbull J; Girard JM; Lohi H; Chan EM; Wang P; Tiberia E; Omer S; Ahmed M; Bennett C; Chakrabarty A; Tyagi A; Liu Y; Pencea N; Zhao X; Scherer SW; Ackerley CA; Minassian BA Brain; 2012 Sep; 135(Pt 9):2684-98. PubMed ID: 22961547 [TBL] [Abstract][Full Text] [Related]